Discharge Prescription of Renin-Angiotensin System Inhibitors After Hyperkalemia and Its Association With Mortality and Dialysis Outcomes
Yarden Weiss, Lior Cohen-Yatziv, Ariel Ben Shimol, Nimrod Adatto Levy, Ilia Beberashvili, Shai Efrati, Shani Zilberman Itskovich · 2026
Read Discharge Prescription of Renin-Angiotensin System Inhibitors After Hyperkalemia and Its Association With Mortality and Dialysis Outcomes by Yarden Weiss, Lior Cohen-Yatziv, Ariel Ben Shimol, Nimrod Adatto Levy, Ilia Beberashvili, Shai Efrati, Shani Zilberman Itskovich (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13334311.txt.
Description
Yarden Weiss and colleagues study 2026 discharge orders for RAS blockers after high potassium and its links to death and kidney-failure treatment results. RAS blockers are often stopped during hospital stay for high potassium, yet guidance on discharge prescribing is limited. The team evaluated links between blocker order at discharge and post-discharge results in patients in hospital with high potassium.
The single-center look-back cohort at a large hospital included adults admitted between 2005 and 2020 with potassium above 5.5 units per litre while on chronic blocker therapy, followed through 2022. Exposure was order versus non-order of blockers at discharge, with score matching among survivors of the first hospital stay to balance start traits. Kaplan-Meier and adjusted Cox models assessed all-cause death and chronic kidney-failure treatment. Among 12,326 patients with confirmed high potassium, results are detailed in the full paper.
Catalog record
| CREATOR | Yarden Weiss, Lior Cohen-Yatziv, Ariel Ben Shimol, Nimrod Adatto Levy, Ilia Beberashvili, Shai Efrati, Shani Zilberman Itskovich |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |